| Glaxosmithkline Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Year | High (₹) | Low (₹) | Close (₹) | P/E High | P/E Low | P/E Close | Market Capital(₹ In Cr) |
|---|---|---|---|---|---|---|---|
| Jun 2022.0 | 1,562.40 | 1,482.00 | 1,499.70 | 15.91 | 14.56 | 15.13 | 25,405.82 |
| May 2022.0 | 1,598.50 | 1,433.05 | 1,514.15 | 16.63 | 13.93 | 15.27 | 25,650.61 |
| Apr 2022.0 | 1,683.70 | 1,564.90 | 1,570.80 | 17.59 | 15.73 | 15.85 | 26,610.30 |
| Mar 2022.0 | 1,734.90 | 1,458.00 | 1,662.95 | 17.93 | 14.25 | 16.78 | 28,171.38 |
| Feb 2022.0 | 1,599.00 | 1,489.25 | 1,519.45 | 59.25 | 52.61 | 54.15 | 25,740.40 |
| Jan 2022.0 | 1,789.45 | 1,536.10 | 1,562.30 | 64.83 | 53.82 | 55.68 | 26,466.30 |
| Dec 2021.0 | 1,917.00 | 1,646.40 | 1,760.50 | 70.38 | 57.01 | 62.74 | 29,823.93 |
| Nov 2021.0 | 1,824.65 | 1,538.00 | 1,702.85 | 67.44 | 52.67 | 60.69 | 28,847.31 |
| Oct 2021.0 | 1,515.00 | 1,450.00 | 1,503.05 | 55.10 | 51.56 | 53.56 | 25,462.57 |
| Sep 2021.0 | 1,603.80 | 1,472.00 | 1,481.15 | 58.20 | 51.55 | 52.78 | 25,091.57 |